This book investigates the mechanistic challenges and prospects of nanomedicines in managing hormone-related cancers. It explores the integration of imaging and drug delivery functions within nanotheranostics for monitoring drug biodistribution and pathology, offering insights into tumor identification and treatment efficacy prediction. The text details the progress in hormone-related cancer management through non-medicinal therapies, focusing on targeting hormone-regulated cancers and discussing their clinical progress and hurdles.

This book appears to be a specialized scientific text aimed at researchers and clinicians in the fields of oncology and nanomedicine. Its focus on mechanistic challenges and prospects suggests a deep dive into the scientific underpinnings of nanomedicine's application to hormone-related cancers. The content likely appeals to a readership seeking detailed information on the latest advancements and potential future directions in cancer therapy.